Zhaoting Li

NMPA Key Laboratory For Research And Evaluation Of Pharmaceutical Preparations And Excipients, State Key Laboratory Of Natural Medicines
Nanjing, 210009, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Redox modulation with a perfluorocarbon nanoparticle to reverse Treg-mediated immunosuppression and enhance anti-tumor immunity.

Redox modulation with a perfluorocarbon nanoparticle to reverse Treg-mediated immunosuppression and enhance anti-tumor immunity.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: January 16, 2023

Site-Specific Polyplex on CCR7 Down-Regulation and T Cell Elevation for Lymphatic Metastasis Blocking on Breast Cancer.

Site-Specific Polyplex on CCR7 Down-Regulation and T Cell Elevation for Lymphatic Metastasis Blocking on Breast Cancer.

Journal: Advanced healthcare materials

Published: May 16, 2022

In situ self-assembled peptide nanofibers for cancer theranostics.

In situ self-assembled peptide nanofibers for cancer theranostics.

Journal: Biomaterials science

Published: July 28, 2021

Fluorine assembly nanocluster breaks the shackles of immunosuppression to turn the cold tumor hot.

Fluorine assembly nanocluster breaks the shackles of immunosuppression to turn the cold tumor hot.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 15, 2020

Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti-PD-L1 immunotherapy.

Targeting pulmonary tumor microenvironment with CXCR4-inhibiting nanocomplex to enhance anti-PD-L1 immunotherapy.

Journal: Science advances

Published: October 21, 2019

Treatment of acute lung injury and early- and late-stage pulmonary fibrosis with combination emulsion siRNA polyplexes.

Treatment of acute lung injury and early- and late-stage pulmonary fibrosis with combination emulsion siRNA polyplexes.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: June 26, 2019

Increased Survival by Pulmonary Treatment of Established Lung Metastases with Dual STAT3/CXCR4 Inhibition by siRNA Nanoemulsions.

Increased Survival by Pulmonary Treatment of Established Lung Metastases with Dual STAT3/CXCR4 Inhibition by siRNA Nanoemulsions.

Journal: Molecular therapy : the journal of the American Society of Gene Therapy

Published: May 31, 2019

Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer.

Reversibly Stabilized Polycation Nanoparticles for Combination Treatment of Early- and Late-Stage Metastatic Breast Cancer.

Journal: ACS nano

Published: July 10, 2018

Anti-VEGFR2-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer.

Anti-VEGFR2-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer.

Journal: Oncoimmunology

Published: December 09, 2016

VEGFR2 targeted antibody fused with MICA stimulates NKG2D mediated immunosurveillance and exhibits potent anti-tumor activity against breast cancer.

VEGFR2 targeted antibody fused with MICA stimulates NKG2D mediated immunosurveillance and exhibits potent anti-tumor activity against breast cancer.

Journal: Oncotarget

Published: August 25, 2015

Showing 1-10 of 10

Last Updated: 09/26/2026